Last Updated:
NameDesignationAppointment DateStatus
Dilip Birdi

Appointed as Whole-time director since December 2019

Whole-time director30-Dec-2019Current
Sanjiv Kumar Kothari

Appointed as Director since October 2018

Director09-Oct-2018Current
Saras Malik

Appointed as Director since August 2019

Director14-Aug-2019Current
Amit Kumar

Appointed as Company Secretary since March 2023

Company Secretary20-Mar-2023Current
Vivek Anand

Appointed as CFO since September 2022

CFO15-Sep-2022Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Premedium Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Premedium Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address Plot No. 14, Sector - 20, Dwarka, Delhi, 110075, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Premedium Pharmaceuticals Private Limited through their registered address at Plot No. 14, Sector - 20, Dwarka, Delhi, 110075, India, or via their website at premediumpharmaceuticals.com. Social media links are also provided where applicable.
The current directors of Premedium Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SANJIV KUMAR KOTHARI
  • SARAS MALIK
  • DILIP BIRDI
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available